2023 ICD-10-CM POA Exempt - Long term (current) drug therapy (Z79)
List of Present On Admission Exempt (POA) ICD-10-CM Codes for: "Long term (current) drug therapy (Z79)" for the fiscal year 2023. There are 32 diagnosis codes exempt from POA reporting in this chapter.
| ICD-10 | Description | Status |
|---|---|---|
| Z79.01 | Long term (current) use of anticoagulants | Billable Code |
| Z79.02 | Long term (current) use of antithrombotics/antiplatelets | Billable Code |
| Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) | Billable Code |
| Z79.2 | Long term (current) use of antibiotics | Billable Code |
| Z79.3 | Long term (current) use of hormonal contraceptives | Billable Code |
| Z79.4 | Long term (current) use of insulin | Billable Code |
| Z79.51 | Long term (current) use of inhaled steroids | Billable Code |
| Z79.52 | Long term (current) use of systemic steroids | Billable Code |
| Z79.60 | Long term (current) use of unspecified immunomodulators and immunosuppressants | Billable Code |
| Z79.61 | Long term (current) use of immunomodulator | Billable Code |
| Z79.620 | Long term (current) use of immunosuppressive biologic | Billable Code |
| Z79.621 | Long term (current) use of calcineurin inhibitor | Billable Code |
| Z79.622 | Long term (current) use of Janus kinase inhibitor | Billable Code |
| Z79.623 | Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor | Billable Code |
| Z79.624 | Long term (current) use of inhibitors of nucleotide synthesis | Billable Code |
| Z79.630 | Long term (current) use of alkylating agent | Billable Code |
| Z79.631 | Long term (current) use of antimetabolite agent | Billable Code |
| Z79.632 | Long term (current) use of antitumor antibiotic | Billable Code |
| Z79.633 | Long term (current) use of mitotic inhibitor | Billable Code |
| Z79.634 | Long term (current) use of topoisomerase inhibitor | Billable Code |
| Z79.64 | Long term (current) use of myelosuppressive agent | Billable Code |
| Z79.69 | Long term (current) use of other immunomodulators and immunosuppressants | Billable Code |
| Z79.810 | Long term (current) use of selective estrogen receptor modulators (SERMs) | Billable Code |
| Z79.811 | Long term (current) use of aromatase inhibitors | Billable Code |
| Z79.818 | Long term (current) use of other agents affecting estrogen receptors and estrogen levels | Billable Code |
| Z79.82 | Long term (current) use of aspirin | Billable Code |
| Z79.83 | Long term (current) use of bisphosphonates | Billable Code |
| Z79.84 | Long term (current) use of oral hypoglycemic drugs | Billable Code |
| Z79.85 | Long-term (current) use of injectable non-insulin antidiabetic drugs | Billable Code |
| Z79.890 | Hormone replacement therapy | Billable Code |
| Z79.891 | Long term (current) use of opiate analgesic | Billable Code |
| Z79.899 | Other long term (current) drug therapy | Billable Code |